Cynthia J. Dieter's Insider Trades & SAST Disclosures
Cynthia J. Dieter's most recent trade in Neogenomics Inc. was a trade of 880 Common Stock done . Disclosure was reported to the exchange on March 1, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Cynthia J. Dieter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2023 | 880 | 29,882 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2023 | 117 | 29,765 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Dec 2022 | 959 | 30,762 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 13,141 | 31,721 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 22 Jun 2022 | 57 | 18,580 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 22,805 | 22,805 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 9,341 | 18,774 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2022 | 137 | 18,637 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2021 | 7,643 | 9,433 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.98 per share. | 22 Jun 2021 | 56 | 1,790 (0%) | 0% | 44.0 | 2,463 | Common Stock |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 7,034 | 7,034 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 1,241 | 1,846 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 3,968 | 3,968 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Cynthia J. Dieter | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 605 | 605 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges